S. F. Lowry

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Kimberly J. Van Zee, Tadahiko Kohno, E Fischer et al. · Proceedings of the National Academy of Sciences · 1992 · 852 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +15

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Yuman Fong, Kevin J. Tracey, Lyle L. Moldawer et al. · The Journal of Experimental Medicine · 1989 · 645 citations · Full text

Veterinary Medicine, Immunology, Microbiology +17

Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.

Stephen D. Wolpe, G. Davatelis, Barbara Sherry et al. · The Journal of Experimental Medicine · 1988 · 580 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.

Tom van der Poll, S M Coyle, K Barbosa et al. · Journal of Clinical Investigation · 1996 · 520 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +12

Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Kevin J. Tracey, S. F. Lowry, Thomas J. Fahey et al. · PubMed · 1987 · 430 citations

Veterinary Medicine, Pharmacology, Veterinary Physiology +9